3-substituted GABA analogs with central nervous system activity: a review.
about
Neuropathic pain: a practical guide for the clinicianNew molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channelsVigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future ProspectsMechanism of Inactivation of Escherichia coli Aspartate Aminotransferase by ( S )-4-Amino-4,5-dihydro-2-furancarboxylic Acid,The Ca2+ channel alpha2delta-1 subunit determines Ca2+ current kinetics in skeletal muscle but not targeting of alpha1S or excitation-contraction couplingAn assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development.An assessment of levetiracetam as an anti-epileptic drug.An assessment of zonisamide as an anti-epileptic drug.Pregabalin: a new anxiolytic.Pregabalin in acute and chronic pain.Discovering New Reactions with N-Heterocyclic Carbene Catalysis.Antiepileptic drugs: how they work in headache.Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injuryThe effectiveness of pregabalin for post-tonsillectomy pain control: a randomized controlled trial.Update on the management of diabetic polyneuropathies.GABA-ergic drugs: exit stage left, enter stage right.Nerve injury-induced calcium channel alpha-2-delta-1 protein dysregulation leads to increased pre-synaptic excitatory input into deep dorsal horn neurons and neuropathic allodyniaEffect of preoperative pregabalin on postoperative pain relief in thyroidectomy patients: A prospective observational study.New targets for neuropathic pain therapeutics.Effects of pregabalin on visceral pain responses and colonic compliance in rats.Enantiomers of 4-amino-3-fluorobutanoic acid as substrates for gamma-aminobutyric acid aminotransferase. Conformational probes for GABA bindingPregabalin in the treatment of spasticity: a retrospective case series.Pregabalin in neuropathic pain: evidences and possible mechanisms.Engineering proteins for custom inhibition of Ca(V) channels.alpha(2)delta Modulators for Management of Compression Neuropathic Pain: A Review of Three Case Series.Conformationally restricted GABA analogs: from rigid carbocycles to cage hydrocarbons.Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.Pharmacologic management of diabetic peripheral neuropathic pain.One-pot synthesis of GABA amides via the nucleophilic addition of amines to 3,3-disubstituted cyclopropenes.Gabapentinoids as a Part of Multi-modal Drug Regime for Pain Relief following Laproscopic Cholecystectomy: A Randomized Study.Highly diastereo- and enantioselective additions of homoenolates to nitrones catalyzed by N-heterocyclic carbenes.Silicon-containing GABA derivatives, silagaba compounds, as orally effective agents for treating neuropathic pain without central-nervous-system-related side effects.Gabapentinium picrateEnantioselective organocatalytic Michael addition of aldehydes to nitroethylene: efficient access to gamma2-amino acids.Stereochemical Control of Enzymatic Carbon-Carbon Bond-Forming Michael-Type Additions by "Substrate Engineering".Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices.
P2860
Q24553796-018DFAC1-5B59-46AD-8E7A-0A9EA5EB20DCQ24654230-DA6D7EAF-56AD-4F71-AB3D-0464A0CCCA47Q24676147-08545EAD-B88E-466C-ABA8-C2A40A498104Q26799409-2E486A04-483B-46E0-A0B9-ABC3C52263A8Q27665437-87215BA3-EFF5-4558-985D-BDAFE061347CQ28593153-6FB7A086-DAA1-4108-A8B6-0AB65E9684F5Q34074818-64186564-1E95-4A90-ACEF-44F40D19F9D8Q34074969-49D1B0BD-E2A3-4322-973B-00D1D4EFD2ABQ34181957-29A0AA01-3A43-4D92-8B87-9353A417EDD3Q34187006-EDBECF22-3170-4C65-8415-DBCD19A6F39BQ34214071-984504C0-FFF7-43D0-9CCD-B1D7CACA847CQ34284871-A52D97D1-B93F-4FDA-AC8A-AF06740B7960Q34570655-F74AD2F9-4211-4D45-9DD6-951AC33A8E26Q34579804-F423A4B5-D4C2-4E57-99BD-49C29627A6CAQ35006462-88994E48-607C-4AEC-8282-7493E7962E37Q35112504-854A4572-352C-411D-81DE-BD544E862891Q35178801-A81B2768-158A-457E-8452-D97AE96DBF5CQ35180791-AA1D3991-F9D6-480B-9E41-2A632D5EC2F2Q35963412-F035C72E-353C-448A-A09A-E93C96D47B2AQ36041169-0DB38143-51F9-4DA1-B174-CCB83669E59EQ36219689-09EBDC75-542F-4F6C-A5DB-44437BD69F49Q36938454-A6E391E8-FCE7-42D3-B53F-3FFB3E5CBCC2Q36944163-6789AC94-7748-4191-AD59-2A9EA80A0E7AQ36974396-370807ED-7D62-4AC0-8FB7-81753CB168B9Q37559818-2F714BFE-90A7-4726-B1DA-9BFED672843CQ37578943-3EFCBD1A-3947-4F65-BCCC-D99CBA961BE5Q37776414-DAF50BA3-85AE-4CF5-9D98-0499A5FDA473Q37856290-90F63ABF-82B0-4708-8BE3-D70850B3D919Q38064486-5FE906DB-0E1A-4368-B812-FCA31313437DQ38116975-8C4AD328-5EB6-47A1-BC20-7016BE553231Q38354402-CFD5FCD0-9D66-4B21-8B45-4559024EF934Q41261160-BABA4031-53D7-4C1A-B918-40E4B5402A30Q41880387-C6A6D8CB-0985-4531-BE82-26F89E4BBF7BQ41992322-8467EC3F-3EEC-42B4-B738-39198E90B75FQ42158768-5FF67A29-8C6F-4437-A60C-C41AF2157000Q42321533-FCC1AC49-DA17-44D2-9F1E-64F1D6ED3751Q42366816-3459430E-F34F-47D8-81D6-309BDE11803EQ42653001-F58CCE03-219D-4E27-A6E3-B4DB72BB94E9Q44030301-A57DF9D5-FD2A-4798-8E84-D88346DF8F64Q44060440-8A4D8F19-CE3C-4AF3-BB13-FC0B07E55F53
P2860
3-substituted GABA analogs with central nervous system activity: a review.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
3-substituted GABA analogs with central nervous system activity: a review.
@ast
3-substituted GABA analogs with central nervous system activity: a review.
@en
3-substituted GABA analogs with central nervous system activity: a review.
@nl
type
label
3-substituted GABA analogs with central nervous system activity: a review.
@ast
3-substituted GABA analogs with central nervous system activity: a review.
@en
3-substituted GABA analogs with central nervous system activity: a review.
@nl
prefLabel
3-substituted GABA analogs with central nervous system activity: a review.
@ast
3-substituted GABA analogs with central nervous system activity: a review.
@en
3-substituted GABA analogs with central nervous system activity: a review.
@nl
P2860
P1476
3-substituted GABA analogs with central nervous system activity: a review.
@en
P2093
D J Wustrow
J S Bryans
P2860
P304
P356
10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B
P577
1999-03-01T00:00:00Z